Markets


Helios and Matheson Analytics Inc Is Still Home on the Bullish Range

S3 Partners explores why bearish sentiment is not responsible for the sharp pullback in HMNY stock today.

Company Update (NASDAQ:INFI): Infinity Pharmaceuticals Inc. to Present Phase 1b IPI-549 Data at the 2017 Society for Immunotherapy of Cancer Annual Meeting

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) announced that clinical data from its IPI-549 Phase 1/1b study was selected as a late-breaking abstract and will be presented on …

Company Update (NASDAQ:CLSN): Celsion Corporation to Host R&D Day After Market Close

Celsion Corporation (NASDAQ:CLSN) announced that it will host a Research and Development (R&D) Day for investors and analysts on Thursday, October 12, 2017.  …

Helios and Matheson Analytics Inc (HMNY) Provides Key Updates on MoviePass Deal

Helios and Matheson Analytics Inc (NASDAQ:HMNY) announced that, since August 15, 2017, it has received aggregate gross cash proceeds of approximately $12.8 million …

Spooked Investors Send AcelRx Pharmaceuticals Inc (ACRX) Shares Into Sea of Red

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) saw its shares crater by as much as 62% today on exceptionally high volume. This drop was triggered by …

Valeant Pharmaceuticals Intl Inc’s (VRX) Ortho Dermatologics Confirms 2-Year Efficacy For Psoriasis Treatment SILIQ

Valeant Pharmaceuticals Intl Inc’s (NYSE:VRX) Ortho Dermatologics division announced results from the Pivotal Phase 3 long-term extension study (AMAGINE-2), which demonstrated that SILIQ™ (brodalumab) …

General Electric Company (GE) Is a Challenged Power Business: J.P. Morgan Gets Even More Bearish

Stephen Tusa trims the price target and warns that “not even a brilliant activist” can fix GE’s problems.

How Does Top Analyst Mark Mahaney See Snap Inc (SNAP) and Facebook Inc (FB) Ahead of Q3 Results?

Here’s why Mark Mahaney “likes” Facebook better than Snap as a tech play for the near-term.

Micron Technology, Inc. (MU) Gets a Price Target Bump from Top Analyst

Top analyst Vijay Rakesh spotlights a buying opportunity thanks to robust DRAM/NAND fundamentals.

Mara Goldstein Bullish on Ardelyx Inc (ARDX) as IBS-C Trial Delivers Positive Results

Tenapanor is a viable drug in the treatment of IBS-C, says Cantor’s Mara Goldstein.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts